Page 63 - e-CPG-SLE-8_5_24

Management of Systemic Lupus Erythematosus

REFERENCES

1. Urowitz MB, Gladman DD, Tom BD, et al. Changing patterns in mortality and
disease outcomes for patients with systemic lupus erythematosus. J Rheumatol.
2008;35(11):2152-2158.
2. Jakes RW, Bae SC, Louthrenoo W, et al. Systematic review of the epidemiology of
systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence,
clinical features, and mortality. Arthritis Care Res (Hoboken). 2012;64(2):159-
168.
3. Teh CL, Ling GR. Causes and predictors of mortality in hospitalized lupus patient
in Sarawak General Hospital, Malaysia. Lupus. 2013;22(1):106-111.
4. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic
lupus erythematosus: recommendations from an international task force. Ann
Rheum Dis. 2014;73(6):958-967.
5. Mok CC, Hamijoyo L, Kasitanon N, et al. The Asia-Pacific League of Associations
for Rheumatology consensus statements on the management of systemic lupus
erythematosus. Lancet Rheumatol. 2021;3(7):e517-e531.
6. Malaysian SLE Association. What is SLE? Malaysian SLE Association; 2023.
[Available at: https://lupusmalaysia.org/what-is-sle/]
7. Kuo CF, Grainge MJ, Valdes AM, et al. Familial Aggregation of Systemic
Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected
Families. JAMA Intern Med. 2015;175(9):1518-1526.
8. Selvaraja M, Too CL, Tan LK, et al. Human leucocyte antigens profiling in
Malay female patients with systemic lupus erythematosus: are we the same or
different? Lupus Sci Med. 2022;9(1):e000554.
9. Selvaraja M, Chin VK, Abdullah M, et al. HLA-DRB1(*)04 as a Risk Allele to
Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of
Malaysia. Front Med (Lausanne). 2021;7:598665.
10. Charoenngam N, Ponvilawan B, Wongtrakul W, et al. Patients with asthma have
a higher risk of systemic lupus erythematosus: a systematic review and meta-
analysis. Clin Rheumatol. 2021;40(2):529-536.
11. Hsiao YP, Tsai JD, Muo CH, et al. Atopic diseases and systemic lupus
erythematosus: an epidemiological study of the risks and correlations. Int J
Environ Res Public Health. 2014;11(8):8112-8122.
12. Parisis D, Bernier C, Chasset F, et al. Impact of tobacco smoking upon disease
risk, activity and therapeutic response in systemic lupus erythematosus: A
systematic review and meta-analysis. Autoimmun Rev. 2019;18(11):102393.
13. Morotti A, Sollaku I, Catalani S, et al. Systematic review and meta-analysis of
epidemiological studies on the association of occupational exposure to free
crystalline silica and systemic lupus erythematosus. Rheumatology (Oxford).
2020;60(1):81-91.
14. Finckh A, Cooper GS, Chibnik LB, et al. Occupational silica and solvent
exposures and risk of systemic lupus erythematosus in urban women. Arthritis
Rheum. 2006;54(11):3648-3654.
15. Rojas-Villarraga A, Torres-Gonzalez JV, Ruiz-Sternberg AM. Safety of hormonal
replacement therapy and oral contraceptives in systemic lupus erythematosus: a
systematic review and meta-analysis. PLoS One. 2014;9(8):e104303.
16. Nightingale AL, Davidson JE, Molta CT, et al. Presentation of SLE in UK
primary care using the Clinical Practice Research Datalink. Lupus Sci Med.
2017;4(1):e000172.
17. Voulgarelis M, Kokori SI, Ioannidis JP, et al. Anaemia in systemic lupus
erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum
Dis. 2000;59(3):217-222.

46